Ardent Health reported third quarter 2026 results that exceeded analyst expectations on both the top and bottom lines. Performance was driven by sequential volume improvements and traction from the IMPACT cost-savings program, which offset a moderate decline in surgical volumes and persistent labor pressures.

Key Highlights

  • Total revenue grew 3.1% year-over-year to $1.62 billion, slightly ahead of the $1.60 billion consensus estimate.
  • Adjusted admissions growth of 2.9% represents a sequential acceleration from the 2.5% increase reported in the second quarter.
  • Adjusted EBITDA reached $138 million, supported by a 4% reduction in salaries, wages, and benefits (SWB) expenses.
  • The company raised its full-year 2026 Adjusted EBITDA guidance midpoint by 1.5% to a range of $500 million to $535 million.
  • Total surgeries decreased 1.9% year-over-year, reflecting a 5.0% decline in inpatient procedures and a 0.6% dip in outpatient surgeries.